Proteomic analysis of fructose-induced fatty liver in hamsters

Metabolism: Clinical and Experimental

Volumn 57, Issue 8, 2008, Pages 1115-1124

  Zhang, Lihe ^a   Perdomo, German ^a   Kim, Dae Hyun ^a   Qu, Shen ^a   Ringquist, Steven ^a   Trucco, Massimo ^a   Dong, H Henry ^a  

^a CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; APOLIPOPROTEIN A1; CARBAMOYL PHOSPHATE SYNTHASE; CHAPERONIN; FATTY ACID BINDING PROTEIN; FRUCTOSE; FRUCTOSE 1,6 BISPHOSPHATE; GLYCEROL KINASE; HEAT SHOCK PROTEIN 70; PEROXIREDOXIN; PROTEIN DISULFIDE ISOMERASE; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; DIETARY INTAKE; DOWN REGULATION; FATTY ACID METABOLISM; FATTY LIVER; HAMSTER; HYPERINSULINEMIA; HYPERLIPIDEMIA; LIPID STORAGE; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEOMICS; UPREGULATION;

ANIMALS; APOLIPOPROTEIN A-I; CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA); CRICETINAE; DIETARY CARBOHYDRATES; FATTY ACID-BINDING PROTEINS; FATTY LIVER; FRUCTOSE; FRUCTOSE-BISPHOSPHATASE; GLUCOSE TOLERANCE TEST; GLYCEROL KINASE; GROEL PROTEIN; HISTOCYTOCHEMISTRY; HSP70 HEAT-SHOCK PROTEINS; HYPERINSULINISM; HYPERLIPIDEMIAS; MALE; MESOCRICETUS; PEROXIREDOXINS; PROTEIN DISULFIDE-ISOMERASE; PROTEOMICS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION;

EID: 47349098124     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.03.017     Document Type: Article

References (84)

1. Bray G.A., Nielsen S.J., and Popkin B.M. Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity. Am J Clin Nutr 79 (2004) 537-543
2. Basciano H., Federico L., and Adeli K. Fructose, insulin resistance, and metabolic dyslipidemia. Nutr Metab (Lond) 2 (2005) 5
3. Qu S., Su D., Altomonte J., et al. PPAR{alpha} mediates the hypolipidemic action of fibrates by antagonizing FoxO1. Am J Physiol Endocrinol Metab 292 (2007) E421-E434
4. Jurgens H., Haass W., Castaneda T.R., et al. Consuming fructose-sweetened beverages increases body adiposity in mice. Obes Res 13 (2005) 1146-1156
5. Avramoglu R.K., Qiu W., and Adeli K. Mechanisms of metabolic dyslipidemia in insulin resistant states: deregulation of hepatic and intestinal lipoprotein secretion. Front Biosci 8 (2003) d464-d476
6. Taghibiglou C., Carpentier A., Van Iderstine S.C., et al. Mechanisms of hepatic very low density lipoprotein overproduction in insulin resistance. Evidence for enhanced lipoprotein assembly, reduced intracellular ApoB degradation, and increased microsomal triglyceride transfer protein in a fructose-fed hamster model. J Biol Chem 275 (2000) 8416-8425
7. Teff K.L., Elliott S.S., Tschop M., et al. Dietary fructose reduces circulating insulin and leptin, attenuates postprandial suppression of ghrelin, and increases triglycerides in women. J Clin Endocrinol Metab 89 (2004) 2963-2972
8. Elliott S.S., Keim N.L., Stern J.S., et al. Fructose, weight gain, and the insulin resistance syndrome. Am J Clin Nutr 76 (2002) 911-922
9. Kohen-Avramoglu R., Theriault A., and Adeli K. Emergence of the metabolic syndrome in childhood: an epidemiological overview and mechanistic link to dyslipidemia. Clin Biochem 36 (2003) 413-420
10. Bantle J.P., Raatz S.K., Thomas W., et al. Effects of dietary fructose on plasma lipids in healthy subjects. Am J Clin Nutr 72 (2000) 1128-1134
11. Ludwig D.S., Peterson K.E., and Gortmaker S.L. Relation between consumption of sugar-sweetened drinks and childhood obesity: a prospective, observational analysis. Lancet 357 (2001) 505-508
12. James J., and Kerr D. Prevention of childhood obesity by reducing soft drinks. Int J Obes 29 Suppl 2 (2005) S54-S57
13. Philippas N.G., and Lo C.W. Childhood obesity: etiology, prevention, and treatment. Nutr Clin Care 8 (2005) 77-88
14. Gibson S.A. Associations between energy density and macronutrient composition in the diets of pre-school children: sugars vs. starch. Int J Obes Relat Metab Disord 24 (2000) 633-638
15. Smith Jr. L.H., Ettinger R.H., and Seligson D. A comparison of the metabolism of fructose and glucose in hepatic disease and diabetes mellitus. J Clin Invest 32 (1953) 273-282
16. Sato Y., Ito T., Udaka N., et al. Immunohistochemical localization of facilitated-diffusion glucose transporters in rat pancreatic islets. Tissue Cell 28 (1996) 637-643
17. Schwartz M.W., and Porte Jr. D. Diabetes, obesity, and the brain. Science 307 (2005) 375-379
18. Schwartz M.W., Woods S.C., Porte Jr. D., et al. Central nervous system control of food intake. Nature 404 (2000) 661-671
19. Havel P.J. Control of energy homeostasis and insulin action by adipocyte hormones: leptin, acylation stimulating protein, and adiponectin. Curr Opin Lipidol 13 (2002) 51-59
20. Woods S.C., Porte Jr. D., Bobbioni E., et al. Insulin: its relationship to the central nervous system and to the control of food intake and body weight. Am J Clin Nutr 42 (1985) 1063-1071
21. Dong H., Altomonte J., Morral N., et al. Basal insulin gene expression significantly improves conventional insulin therapy in type 1 diabetic rats. Diabetes 51 (2002) 130-138
22. Qu S., Altomonte J., Perdomo G., et al. Aberrant forkhead box O1 function is associated with impaired hepatic metabolism. Endocrinology 147 (2006) 5641-5652
23. Carpentier A., Taghibiglou C., Leung N., et al. Ameliorated hepatic insulin resistance is associated with normalization of microsomal triglyceride transfer protein expression and reduction in very low density lipoprotein assembly and secretion in the fructose-fed hamster. J Biol Chem 277 (2002) 28795-28802
24. Chong T., Naples M., Federico L., et al. Effect of rosuvastatin on hepatic production of apolipoprotein B-containing lipoproteins in an animal model of insulin resistance and metabolic dyslipidemia. Atherosclerosis 185 (2006) 21-31
25. Hoekstra M., Stitzinger M., van Wanrooij E.J., et al. Microarray analysis indicates an important role for FABP5 and putative novel FABPs on a Western-type diet. J Lipid Res 47 (2006) 2198-2207
26. Lieber C.S. Alcoholic fatty liver: its pathogenesis and mechanism of progression to inflammation and fibrosis. Alcohol 34 (2004) 9-19
27. Newberry E.P., Xie Y., Kennedy S.M., et al. Protection against Western diet-induced obesity and hepatic steatosis in liver fatty acid-binding protein knockout mice. Hepatology 44 (2006) 1191-1205
28. Spann N.J., Kang S., Li A.C., et al. Coordinate transcriptional repression of liver fatty acid-binding protein and microsomal triglyceride transfer protein blocks hepatic very low density lipoprotein secretion without hepatosteatosis. J Biol Chem 281 (2006) 33066-33077
29. Cao H., Maeda K., Gorgun C.Z., et al. Regulation of metabolic responses by adipocyte/macrophage fatty acid-binding proteins in leptin-deficient mice. Diabetes 55 (2006) 1915-1922
30. Aoyama Y., Yoshida A., and Ashida K. Effect of dietary fats and fatty acids on the liver lipid accumulation induced by feeding a protein-repletion diet containing fructose to protein-depleted rats. J Nutr 104 (1974) 741-746
31. Mayes P.A. Intermediary metabolism of fructose. Am J Clin Nutr 58 (1993) 754S-765S
32. Hallfrisch J. Metabolic effects of dietary fructose. FASEB J 4 (1990) 2652-2660
33. Wetterau J.R., Combs K.A., McLean L.R., et al. Protein disulfide isomerase appears necessary to maintain the catalytically active structure of the microsomal triglyceride transfer protein. Biochemistry 30 (1991) 9728-9735
34. Wetterau J.R., Aggerbeck L.P., Laplaud P.M., et al. Structural properties of the microsomal triglyceride-transfer protein complex. Biochemistry 30 (1991) 4406-4412
35. Satoh M., Shimada A., Kashiwai A., et al. Differential cooperative enzymatic activities of protein disulfide isomerase family in protein folding. Cell Stress Chaperones 10 (2005) 211-220
36. Berriot-Varoqueaux N., Aggerbeck L.P., Samson-Bouma M., et al. The role of the microsomal triglygeride transfer protein in abetalipoproteinemia. Annu Rev Nutr 20 (2000) 663-697
37. Hussain M.M., Shi J., and Dreizen P. Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly. J Lipid Res 44 (2003) 22-32
38. Guo Q., Wang P.R., Milot D.P., et al. Regulation of lipid metabolism and gene expression by fenofibrate in hamsters. Biochim Biophys Acta 1533 (2001) 220-232
39. Barter P.J., and Rye K.A. The rationale for using apoA-I as a clinical marker of cardiovascular risk. J Intern Med 259 (2006) 447-454
40. Chau P., Nakamura Y., Fielding C.J., et al. Mechanism of prebeta-HDL formation and activation. Biochemistry 45 (2006) 3981-3987
41. Rye K.A., and Barter P.J. Formation and metabolism of prebeta-migrating, lipid-poor apolipoprotein A-I. Arterioscler Thromb Vasc Biol 24 (2004) 421-428
42. Lewis G.F., and Rader D.J. New insights into the regulation of HDL metabolism and reverse cholesterol transport. Circ Res 96 (2005) 1221-1232
43. Stein O., Ben-Naim M., Dabach Y., et al. Macrophage cholesterol efflux to free apoprotein A-I in C3H and C57BL/6 mice. Biochem Biophys Res Commun 290 (2002) 1376-1381
44. Tangirala R.K., Tsukamoto K., Chun S.H., et al. Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice. Circulation 100 (1999) 1816-1822
45. Gruen M.L., Plummer M.R., Zhang W., et al. Persistence of high density lipoprotein particles in obese mice lacking apolipoprotein A-I. J Lipid Res 46 (2005) 2007-2014
46. Low F.M., Hampton M.B., Peskin A.V., et al. Peroxiredoxin 2 functions as a noncatalytic scavenger of low-level hydrogen peroxide in the erythrocyte. Blood 109 (2007) 2611-2617
47. Yang C.S., Lee D.S., Song C.H., et al. Roles of peroxiredoxin II in the regulation of proinflammatory responses to LPS and protection against endotoxin-induced lethal shock. J Exp Med 204 (2007) 583-594
48. Kim B.J., Hood B.L., Aragon R.A., et al. Increased oxidation and degradation of cytosolic proteins in alcohol-exposed mouse liver and hepatoma cells. Proteomics 6 (2006) 1250-1260
49. Shau H., Merino A., Chen L., et al. Induction of peroxiredoxins in transplanted livers and demonstration of their in vitro cytoprotection activity. Antioxid Redox Signal 2 (2000) 347-354
50. Cesaratto L., Vascotto C., D'Ambrosio C., et al. Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. Free Radic Res 39 (2005) 255-268
51. Herzog B., Waltner-Law M., Scott D.K., et al. Characterization of the human liver fructose-1,6-bisphosphatase gene promoter. Biochem J 351 Pt 2 (2000) 385-392
52. Lamont B.J., Visinoni S., Fam B.C., et al. Expression of human fructose-1,6-bisphosphatase in the liver of transgenic mice results in increased glycerol gluconeogenesis. Endocrinology 147 (2006) 2764-2772
53. Kondo H., Minegishi Y., Komine Y., et al. Differential regulation of intestinal lipid metabolism-related genes in obesity-resistant A/J vs. obesity-prone C57BL/6J mice. Am J Physiol Endocrinol Metab 291 (2006) E1092-E1099
54. Josch C., Klotz L.O., and Sies H. Identification of cytosolic leucyl aminopeptidase (EC 3.4.11.1) as the major cysteinylglycine-hydrolysing activity in rat liver. Biol Chem 384 (2003) 213-218
55. Cappiello M., Lazzarotti A., Buono F., et al. New role for leucyl aminopeptidase in glutathione turnover. Biochem J 378 (2004) 35-44
56. Curry S., Brick P., and Franks N.P. Fatty acid binding to human serum albumin: new insights from crystallographic studies. Biochim Biophys Acta 1441 (1999) 131-140
57. Summar M.L., Hall L., Christman B., et al. Environmentally determined genetic expression: clinical correlates with molecular variants of carbamyl phosphate synthetase I. Mol Genet Metab 81 Suppl 1 (2004) S12-S19
58. Inoue Y., Inoue J., Lambert G., et al. Disruption of hepatic C/EBPalpha results in impaired glucose tolerance and age-dependent hepatosteatosis. J Biol Chem 279 (2004) 44740-44748
59. Tsybovsky Y., Donato H., Krupenko N.I., et al. Crystal structures of the carboxyl terminal domain of rat 10-formyltetrahydrofolate dehydrogenase: implications for the catalytic mechanism of aldehyde dehydrogenases. Biochemistry 46 (2007) 2917-2929
60. Anguera M.C., Field M.S., Perry C., et al. Regulation of folate-mediated one-carbon metabolism by 10-formyltetrahydrofolate dehydrogenase. J Biol Chem 281 (2006) 18335-18342
61. Min H., Shane B., and Stokstad E.L. Identification of 10-formyltetrahydrofolate dehydrogenase-hydrolase as a major folate binding protein in liver cytosol. Biochim Biophys Acta 967 (1988) 348-353
62. Neymeyer V.R., and Tephly T.R. Detection and quantification of 10-formyltetrahydrofolate dehydrogenase (10-FTHFDH) in rat retina, optic nerve, and brain. Life Sci 54 (1994) PL395-PL399
63. Neymeyer V., Tephly T.R., and Miller M.W. Folate and 10-formyltetrahydrofolate dehydrogenase (FDH) expression in the central nervous system of the mature rat. Brain Res 766 (1997) 195-204
64. Min H., Im E.S., Seo J.S., et al. Effects of chronic ethanol ingestion and folate deficiency on the activity of 10-formyltetrahydrofolate dehydrogenase in rat liver. Alcohol Clin Exp Res 29 (2005) 2188-2193
65. Maruyama N., Ishigami A., Kuramoto M., et al. Senescence marker protein-30 knockout mouse as an aging model. Ann N Y Acad Sci 1019 (2004) 383-387
66. Kondo Y., Inai Y., Sato Y., et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice areprone to scurvy. Proc Natl Acad Sci U S A 103 (2006) 5723-5728
67. Ishigami A., Kondo Y., Nanba R., et al. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 315 (2004) 575-580
68. Park J.Y., Seong J.K., and Paik Y.K. Proteomic analysis of diet-induced hypercholesterolemic mice. Proteomics 4 (2004) 514-523
69. Levi B., and Werman M.J. Long-term fructose consumption accelerates glycation and several age-related variables in male rats. J Nutr 128 (1998) 1442-1449
70. Mikulikova K., Eckhardt A., Kunes J., et al. Advanced glycation end-product pentosidine accumulates in various tissues of rats with high fructose intake. Physiol Res (2007)
71. Rashid K.A., Hevi S., Chen Y., et al. A proteomic approach identifies proteins in hepatocytes that bind nascent apolipoprotein B. J Biol Chem 277 (2002) 22010-22017
72. Hevi S., and Chuck S.L. Ferritins can regulate the secretion of apolipoprotein B. J Biol Chem 278 (2003) 31924-31929
73. Whitfield A.J., Barrett P.H., Robertson K., et al. Liver dysfunction and steatosis in familial hypobetalipoproteinemia. Clin Chem 51 (2005) 266-269
74. Taghibiglou C., Van Iderstine S.C., Kulinski A., et al. Intracellular mechanisms mediating the inhibition of apoB-containing lipoprotein synthesis and secretion in HepG2 cells by avasimibe (CI-1011), a novel acyl-coenzyme A: cholesterol acyltransferase (ACAT) inhibitor. Biochem Pharmacol 63 (2002) 349-360
75. Taghibiglou C., Rashid-Kolvear F., Van Iderstine S.C., et al. Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance. J Biol Chem 277 (2002) 793-803
76. Fields M., Ferretti R.J., Reiser S., et al. The severity of copper deficiency in rats is determined by the type of dietary carbohydrate. Proc Soc Exp Biol Med 175 (1984) 530-537
77. Busserolles J., Rock E., Gueux E., et al. Short-term consumption of a high-sucrose diet has a pro-oxidant effect in rats. Br J Nutr 87 (2002) 337-342
78. Busserolles J., Zimowska W., Rock E., et al. Rats fed a high sucrose diet have altered heart antioxidant enzyme activity and gene expression. Life Sci 71 (2002) 1303-1312
79. Busserolles J., Gueux E., Rock E., et al. High fructose feeding of magnesium deficient rats is associated with increased plasma triglyceride concentration and increased oxidative stress. Magnes Res 16 (2003) 7-12
80. Busserolles J., Gueux E., Rock E., et al. Substituting honey for refined carbohydrates protects rats from hypertriglyceridemic and prooxidative effects of fructose. J Nutr 132 (2002) 3379-3382
81. Faure P., Rossini E., Lafond J.L., et al. Vitamin E improves the free radical defense system potential and insulin sensitivity of rats fed high fructose diets. J Nutr 127 (1997) 103-107
82. Morand J.P., Macri J., and Adeli K. Proteomic profiling of hepatic endoplasmic reticulum-associated proteins in an animal model of insulin resistance and metabolic dyslipidemia. J Biol Chem 280 (2005) 17626-17633
83. Ostos M.A., Recalde D., Baroukh N., et al. Fructose intake increases hyperlipidemia and modifies apolipoprotein expression in apolipoprotein AI-CIII-AIV transgenic mice. J Nutr 132 (2002) 918-923
84. Raben A., Vasilaras T.H., Moller A.C., et al. Sucrose compared with artificial sweeteners: different effects on ad libitum food intake and body weight after 10 wk of supplementation in overweight subjects. Am J Clin Nutr 76 (2002) 721-729